Fibroheal Woundcare, a startup specialising in silk protein-based medical devices, has raised Rs 6.3 crore in its pre-Series A funding round from existing promoters and new investors, including surgeons, medical professionals, and bankers.

They have secured an additional commitment of Rs 10 crore from existing and new investors.

The funds will be utilised to enhance its go-to-market strategy, expand its workforce, and invest in the development of its medical device product pipeline.

Founded in 2017 by Vivek Mishra and Bharat Tandon, Fibroheal’s products are available in over 500 hospitals across 19 states in India. The company also sells its products on various e-commerce platforms.

Its product portfolio includes foams, mesh, powders, and other items designed to treat various acute, chronic, traumatic, post-operative, non-healing, or complex wounds, such as bed sores and infected C-section wounds.

Fibroheal has previously raised funds from Telama Investments, CCAMP, and KITVEN.

Tired of guessing stocks to trade in daily? Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!